Skip to content

Services

Six stages, in this order.

Most of the work happens before anything is filed. We assess what you qualify for, underwrite the company the way a U.S. investor would, and tell you plainly whether U.S. access improves your position. Capital is discussed after that.

We coordinate the work with qualified specialists. We are not a law firm, a dealer or an investment adviser, and nothing here is an offer to buy or sell securities.

01

Assessment

We test what you have against what the MJDS forms actually require, and name every gap.

A written eligibility and readiness position, with every gap named and every threshold sourced.

What’s included
  • MJDS eligibility & readiness assessment

    A preliminary review of your reporting history, Canadian listing, public float, affiliate concentration and foreign private issuer status. We tell you what you may qualify for and what would have to change; final determinations are counsel's.

  • Disclosure and readiness gap review

    What your current Canadian disclosure does not yet say, what the F-10 will expose, and the order in which the gaps have to close. Priced and sequenced before you commit.

02

Light underwriting

We look at the company the way a U.S. investor, analyst and banker would before anyone spends on filings.

A written view: proceed, take a lighter route, or stay where you are.

What’s included
  • Company underwriting review

    Revenue, sector, growth, float, ownership concentration and how the stock actually trades on its Canadian venue. The same questions a U.S. investor asks before buying a foreign private issuer.

  • U.S. investor and coverage map

    Who would own this stock in the U.S., whether sell-side coverage is realistic at your size, and how comparable Canadian issuers have fared on U.S. venues. Coverage is not something a listing creates.

  • Go / no-go recommendation

    A short written recommendation with the reasoning attached. Sometimes it is a full exchange listing, sometimes OTCQX, sometimes staying in Canada and revisiting in a year. We will say so.

03

Route and structure

We choose the form, the venue and the sequence against your float and your first eighteen months.

The specific form, venue and sequence, with cost and timing attached to each.

What’s included
  • Route selection and structuring

    F-10, 40-F, F-7, F-8, F-80, or a tender offer exemption. Exchange versus OTCQX. Chosen against your float, your shareholder base and what you intend to do in the first eighteen months.

  • U.S. securities counsel

    MJDS-experienced counsel for the F-10, the F-X appointments and the SEC comment process. We hold the timetable and read every draft before it goes out.

  • Canadian securities counsel coordination

    The Canadian shelf and the MJDS-format disclosure that feeds it, run to one calendar with the U.S. side rather than in parallel.

04

Building to standard

We put the audit, controls, board, insurance, transfer agent and listing application into one calendar.

Each workstream scoped, owned and scheduled against the others.

What’s included
  • PCAOB audit readiness

    Auditor selection, IFRS or U.S. GAAP alignment and the first PCAOB audit cycle, scoped before the filing date is set.

  • SOX and internal-control readiness

    Scoping, documentation and testing before management has to report on it, and before the auditor has to attest.

  • Board and audit committee build-out

    Independence, the financial expert designation and the committee charter, sized to the venue you are actually targeting.

  • D&O insurance for U.S. exposure

    Incremental U.S. securities cover placed before the first filing rather than after the first claim.

  • Transfer agent and DTC eligibility

    U.S. co-agent arrangements, DTC eligibility and a round-lot holder count that will pass the venue's test on the day it is measured.

  • SEC filing agent

    EDGAR access, F-10 and 40-F filing, 6-K furnishing and XBRL tagging, tested on a dry run before the live filing.

  • Exchange listing or OTCQX application

    Tier selection, price and float gap closure, and the application package. We tell you when the gaps are not closeable in time.

05

Capital formation

We carry the underwriting file into banker and investor discussions and structure what actually fits.

Introductions and structures that fit, or a plain reason a raise is not advisable yet.

What’s included
  • Banking partner selection

    A short list of registered dealers that genuinely cover Canadian issuers of your size and sector, approached with the underwriting file rather than a cold pitch. An introduction is not a commitment to raise, and any placement is executed by the dealer, not by this desk.

  • Capital raise structuring

    Registered directs, registered convertibles and U.S. ATM programmes, sized against your float and your trading volume. This is advisory and coordination work: any offering is executed through a registered dealer, and MJDS Advisory does not act as a dealer or sell securities.

06

After the listing

We run the U.S. reporting calendar and keep foreign private issuer status confirmed, not assumed.

A standing reporting calendar and a monitored foreign private issuer position.

What’s included
  • Investor relations and U.S. marketing

    A U.S. investor programme matched to the float and liquidity you actually have, not to the listing you just paid for.

  • Foreign private issuer status monitoring

    Quarterly tracking of the five inputs and the annual measurement date, so status is confirmed rather than assumed.

Start at stage one.

Send the ticker and where you are in the process. The first conversation is about whether a U.S. path makes sense for your company, not about a financing.

Talk to the desk